Likely, bortezomib also causes the accumulation of ubiquitins in lung cancer cell A549, but P62 does not appear to increase with bortezomib in HeLa cells as reported by others (47), but decrease with bortezomib, indicating that there are variable mechanisms underneath the different DUB inhibitors. This evidence concerns the gene SQSTM1 and lung cancer.